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ABSTRACT Glycogen synthase kinase-3
(GSK-3) is a highly conserved serine/threonine protein
kinase implicated in diverse cellular processes. Activity
of GSK-3 is essential for meiotic chromatin segregation
in oocytes, yet expression and/or function of GSK-3
have not been reported in mammalian preimplantation
embryos. Objectives of this study were to characterize
GSK-3 protein expression/phosphorylation in mouse
preimplantation embryos, to assess the effect of GSK-3
activity inhibition on early mitotic events, and to
differentiate nuclear and cytoplasmic anomalies in
GSK-3 inhibited embryos. Both GSK-3 isoforms were
expressed during embryo development, with a differ-
ential expression of a versus b. Phosphorylation of
GSK-3a/b at residues Y279/Y216 indicated constitu-
tive activation throughout preimplantation develop-
ment. Phosphorylation at N-terminal residues S21/S9
indicated inhibition of GSK-3a/b activity that was
differentially regulated during early development; both
a and b isoforms were phosphorylated during early
divisions, whereas at the blastocyst stage, only b was
phosphorylated. Cytoplasmic microinjection of zygotes
with anti-GSK-3a/b antibody significantly compro-
mised embryonic development past the two-cell stage
compared to controls. Reversibility of developmental
block was tested via pharmacological inhibitors of
GSK-3, lithium chloride (LiCl) and alsterpaullone.
Similar to immunoneutralization, significantly fewer
zygotes cultured with either LiCl or alsterpaullone
developed past the two-cell stage compared to controls
and this mitotic block was not reversible. Inhibition of
GSK-3 activity significantly compromised timing of
pronuclear membrane breakdown and mitosis initia-
tion, nuclear development, and cytokinesis. Inhibition
of GSK-3 also resulted in abnormal chromatin segrega-
tion, evidenced by incomplete karyokinesis and micro-
nuclei formation. These results suggest that GSK-3
activity is critical for early preimplantation embryonic
development. Mol. Reprod. Dev. 74: 178–188,
2007.  2006 Wiley-Liss, Inc.
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INTRODUCTION
Oocyte meiotic and embryo mitotic competence are
directly associated with proper spindle function and
chromosome segregation (Generoso et al., 1989; Batta-
glia et al., 1996; Sun et al., 2005). The first mitotic M
phase is characterized by alignment of condensed
chromatin on a metaphase plate, separation of sister
chromatids by a microtubular spindle apparatus, and
microfilament-mediated cleavage of zygotic cytoplasm
into two cells termed cytokinesis (Kaufman, 1973;
Inoue, 1981; Ciemerych and Czolowska, 1993; Collas
et al., 1999). Each cell, or blastomere, in two-cell
embryos contains a complete complement of chromo-
somes.Disruption ofmicrotubule functionduring oocyte
maturation or fertilization leads to aberrations in
embryo chromosomal ploidy (Generoso et al., 1989; Yu
et al., 2002; Sun et al., 2005). Although oocyte-derived
mRNA and protein products contribute to the first few
embryonic divisions, mouse embryos undergoes major
zygotic genomic activation (ZGA), during the two-cell
stage, to sustain early preimplantation development
(Haraguchi et al., 1998).
Major intracellular events mediating first embryonic
divisions are not clearly understood. Nevertheless, it is
known that cell cycle progression is regulated by
reversible protein phosphorylation. Earlier studies
indicated that transient changes in c-mos proto-onco-
gene product (Mos), mitogen-activated protein (MAP)
kinases ERK1/2, and M-phase promoting factor (MPF)
activities occur during the first cell cycle, independent of
nuclear or exogenous mitogenic control (Masui and
Markert, 1971; Ciemerych, 1995; Winston and Maro,
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1995). Transition from a meiotic to mitotic cell cycle in
fertilized mammalian oocytes requires transient inacti-
vation of MPF and Mos, that in turn mediate activation
ofMAPkinases (Verlhac et al., 1993, 1996; Gebauer and
Richter, 1997; Josefsberg et al., 2003). In somatic cells,
activation of MAP kinases, ERK1 and 2, is required for
initiation of mitosis, nuclear translocation of cyclin B1,
timely progression from metaphase to anaphase, and
regulation of spindle assembly (Robinson and Cobb,
1997; Guadagno and Ferrell, 1998; Roberts et al., 2002;
Horne andGuadagno, 2003; Liu et al., 2004). Activation
of ERK1/2 occurs during meiotic maturation in mouse
oocytes (Verlhac et al., 1996; Lu et al., 2002). However,
high MAP kinase activity in the absence of ERK
activation in early mouse embryo suggests that an
additional MAP kinase signaling cascade may exist at
this stage of development (Haraguchi et al., 1998).
Additionally, the phosphotidylinositol-3-kinase (PI3K)
pathway facilitates cell cycle progression at onset of
mitosis and is required for completion of themammalian
cell cycle via regulation of protein kinase B (PKB).
Despite importance of the PI3K pathway, downstream
effectors in this pathway are not well characterized
(Roberts et al., 2002;Alvarez et al., 2003).More recently,
Polo and Aurora kinases were found to regulate mitotic
spindle function through microtubule-dependent and
independent mechanisms (Doxsey, 2001; Hannak et al.,
2001; do Carmo Avides et al., 2001; Delaval et al., 2004).
These studies suggest that the full array of kinases
that control early mitotic events has not been elucidat-
ed, thus validating further investigation of potential
regulators.
Glycogen synthase kinase-3 (GSK-3) is a serine/
threonine protein kinase that consists of two isoforms,
a and b, and regulation of GSK-3 activity occurs via
reversible phosphorylation. Constitutive phosphoryla-
tion of its tyrosine (Y279 of a/Y216 of b) residues leads to
GSK-3 activation, whereas regulated phosphorylation
of its serine (S21 of a/S9 of b) residues results in
inactivation (Embi et al., 1980; Welsh and Proud,
1993). Cellular processes that utilize GSK-3 include
glycogen metabolism, specification of cell fates during
post-implantation embryo development, control of cell
division,microtubule dynamics and chromosomal align-
ment, and apoptosis (Embi et al., 1980; Klein and
Melton, 1996; Cohen and Frame, 2001; Loberg et al.,
2002; Cho and Johnson, 2003; Wakefield et al., 2003;
Wang et al., 2003). GSK-3 has been shown to play a
major role in early morphogenesis of invertebrate and
vertebrate embryos, including Xenopus (Dominguez
et al., 1995; Pierce and Kimelman, 1995; Klein and
Melton, 1996), sea urchins (Davidson et al., 1998),
zebrafish (Sumoy et al., 1999), and mice (Ossipova
et al., 2003). However, the role of GSK-3 in regulation of
mammalian oocyte and preimplantation embryo devel-
opment is not well understood.
Several studies have implicated GSK-3 in regulation
of microtubule dynamics during mitosis. Glycogen
synthase kinsase-3 appears necessary for development
of a competent spindle apparatus and thus successful
chromosomal segregation (Lovestone et al., 1996;
Doxsey, 2001; Wakefield et al., 2003). In neuronal cells,
changes inmicrotubule dynamics observed duringmito-
sis occur concurrently with phosphorylation of several
microtubule-associated proteins (MAPs), including tau
(Lovestone et al., 1996, 1999; Sang et al., 2001;
Wakefield et al., 2003). Active GSK-3 has been shown
to phosphorylate these MAPs (Woodgett, 1990). While
MAPs have been best characterized in neurons, it is
unknown if they regulate microtubular spindle dyna-
mics in oocytes or embryos. In HeLa cells, GSK-3 is
phosphorylated along the spindle apparatus in a tempo-
ral and spatial manner during mitosis, and inhibition
of GSK-3 activity promotes mitotic spindle defects,
impairs chromosomal movement, and induces improper
chromosomal alignment/segregation (Wakefield et al.,
2003). Recently, GSK-3 activity was shown to be
essential for normal oocyte meiotic chromatin segrega-
tion, but the mechanism of GSK-3-mediated homologue
segregation has not been investigated (Wang et al.,
2003). Collectively, these reports support thehypothesis
of GSK-3 regulating meiotic and mitotic chromatin
segregation.
Lithium chloride (LiCl) inhibition of GSK-3 activity
in living cell cultures has been well characterized in
various systems, including Xenopus and sea urchin
oocytes and embryos (Klein and Melton, 1996; Hedge-
peth et al., 1997, 1999a,b; Emily-Fenouil et al., 1998;
Vonica et al., 2000). Lithium potently inhibits GSK-3,
however, its specificity for GSK-3 has been questioned
because of its ability to inhibit alternative targets,
including inositolmonophosphatase [IMPase] (Berridge
et al., 1989; Stambolic et al., 1996). Paullones, particu-
larly alsterpaullone, potently and selectively inhibit
GSK-3 and cyclin-dependent kinases (CDKs) 1/2/5
activity in cell-free extracts, but display a greater
selectivity for inhibiting GSK-3 in cell culture (Leost
et al., 2000; Tatebayashi et al., 2004). Lithium, on the
other hand, has not been shown to regulate the
inhibition of any known CDK (Klein and Melton, 1996;
Davies et al., 2000; Phiel and Klein, 2001). Comparison
of the effects of paullones and LiCl on inhibition of
protein kinases in cell-free extracts suggests that the
combineduse of these compoundsmayhelp identify both
physiological substrates and roles of GSK-3 (Davies
et al., 2000; Bain et al., 2003). For these reasons, a
combinatorial approach of lithium and alsterpaullone
pharmacological inhibition may serve as a powerful tool
for understanding roles of GSK-3 regulation in early
preimplantation embryos.
At present, there are no reports on presence or funct-
ion of GSK-3a or b inmammalian preimplantion embry-
os. Objectives of this study were to characterize GSK-3a
and b expression/phosphorylation in preimplantation
embryos, assess effects of GSK-3 inhibition on early
mitotic events, and differentiate nuclear and cytoplas-
mic anomalies in GSK-3 inhibited embryos. Our results
indicate that in mammalian embryos, GSK-3 activity
regulatesmitotic cell cycle progression and is critical for
normal chromatin segregation and cytokinesis.
Molecular Reproduction and Development. DOI 10.1002/mrd
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MATERIALS AND METHODS
Collection of Oocytes and
Preimplantation Mouse Embryos
Animals used in these experiments were treated in
accordance with approved protocols by the Animal Care
and Use Committee of the University of Michigan.
Chemicals were purchased from Sigma Chemical Co.
(St. Louis, MO), unless otherwise indicated. To isolate
matureoocytes, oviductswerecollected from6to8weeks
old CF-1 mice stimulated with 10 IU each of equine
chorionic gonadotropin (eCG) and human chorionic
gonadotropin (hCG) administered 48 hr apart. In vivo-
matured metaphase II (MII) oocytes were isolated into
HEPES buffered Human Tubal Fluid media (HTFH;
Irvine Scientific, Santa Ana, CA)þ0.3% (wt/vol) poly-
vinylpyrrolidine (PVP) then frozen in liquid nitrogen
and stored at 808C until protein extracts were pre-
pared. To isolate one-cell embryos (zygotes), oviducts
were collected from 6 to 8 weeks old CF-1 mice
stimulated with 10 IU each of eCG and hCG adminis-
tered 48 hr apart, then mated with CF-1 males.
Cumulus-enclosed zygotes were isolated into HEPES
buffered KSOM media (H-KSOM; as described pre-
viously (Lawitts and Biggers, 1993)þ0.3% (wt/vol)
bovine serum albumin (BSA; Fisher Scientific, Pitts-
burgh, PA) and cumulus cells removed with hyaluroni-
dase. Zygotes were cultured in KSOM media with ½
amino acids and glucose (SpecialtyMedia, Phillipsburg,
NJ)þ3% (wt/vol) BSA for up to 96 hr. For Western blot
analyses, cumulus-free zygotes, two-cell, four-cell, and
blastocyst-stage embryos were washed in H-KSOMþ
0.3% (wt/vol) PVP, then frozen in liquid nitrogen and
stored at 808C until protein extracts were prepared.
For culture experiments, zygotes were placed either in
KSOMþ3% BSA (KSOM alone) or containing potas-
sium chloride (KCl; Fisher Scientific), LiCl, alsterpaul-
lone (Calbiochem, SanDiego, CA), or L-690, 330 (Tocris,
Ballwin, MO).
Electrophoresis and Western Blot Analysis
Frozen cumulus cell-free MII oocytes, zygotes, two-
cell, four-cell, and blastocyst stage embryos were
thawed in 2X SDS–PAGE sample buffer [80 mM Tris-
HCL (pH 6.8), 20% (vol/vol) glycerol, 4% (wt/vol) SDS,
4% (vol/vol) 2-mercaptoethanol, and 0.04% (wt/vol)
bromophenol blue], vortexed, and placed on ice for
15 min. Following sonication on ice for 10 sec, samples
were denatured at 908C for 10 min and cooled on ice for
5 min. One microgram of mouse brain and entire cell
lysates of embryos (N¼80–200) were added per lane
and separated by one-dimensional SDS–PAGE as des-
cribed previously (Wang et al., 2003). Blots were either
probed with anti-GSK-3a/b (Upstate Biotechnology,
Charlottesville, VA), anti-phosphotyrosine-GSK-3a/b
(Y279/216; Upstate Biotechnology), or anti-phosphoser-
ine-GSK-3a/b (Ser 21/9; Cell Signaling Technology,
Beverly, MA). Blots were performed in duplicate and
visualized with ECL Plus chemiluminescence reagents
(Amersham Life Sciences, Buckinghamshire, UK). Iso-
form protein levels were compared within developmen-
tal stages via densitometry analysis.
Immunocytochemistry
Zygotes were isolated and cultured in KSOMþ 3%
BSA to identify localization of GSK-3 during the first
mitotic metaphase. At 35 hr post-hCG administration,
embryos were fixed and permeabilized in 2% (wt/vol)
paraformaldehyde with 0.5% (vol/vol) Triton-X-100 for
45 min at 378C. Embryos were washed three times then
blocked overnight at 48C with a solution of PBS
containing 2% BSA, 2% powdered milk, 0.1 M glycine,
and 0.5% Triton-X-100. Primary antibody incubations
were carried out for 1 hr at 378 in humidified chambers.
The following primary antibodies were used: anti-GSK-
3a/b (1:100;UpstateBiotechnology), anti-GSK-3a (1:50;
Abgent, San Diego, CA), and b-tubulin (1:200; Sigma).
Nonimmunemouse and rabbit serum (NIMS andNIRS,
respectively) were substituted for primary antibodies as
negative controls. Staining was visualized using the
following secondary antibodies: anti-mouse Alexa
Fluor1 568, anti-rabbit Alexa Fluor1 568, and anti-
mouse Alexa Fluor1 488 (all 1:750; Molecular Probes,
Eugene, OR). Chromatin was counterstained with
mounting solution containing Hoescht 33342 (Sigma).
Antibody Microinjection
Zygotes were collected as described above and placed
into HTFHþPVP medium, then microinjected on a
Nikon inverted microscope with Hoffman optics equip-
ped with Narishige micromanipulators and a Brink-
mann Eppendorf microinjector (Brinkmann Eppendorf,
Westbury, NY). Zygotes were cytoplasmically micro-
injected at 400 magnification with 6 pl of undiluted
anti-GSK-3a/b (Upstate Biotechnology, Lake Placid,
NY). Microinjected volumes were confirmed as pre-
viously described (Corson and Fein, 1983). Controls for
the antibody microinjection included injection of mouse
serum IgG, phosphate buffered saline (PBS, pH¼ 7.4;
vehicle control for mouse IgG), or antibody diluent
[0.1MTris-glycine (pH 7.4), 0.15MNaCl, 0.05% sodium
azide; vehicle control for antibody]. Following micro-
injection, embryos were cultured for 48 hr in 50 ml
microdrops of KSOM media overlayed with mineral oil.
Embryos were microscopically assessed at 24-hr inter-
vals for cleavage events.
Pharmacological Inhibition of GSK-3
and Morphological Analyses
Zygotes were collected as described above and cul-
tured for 72 hr in KSOM alone or containing 1, 10, or
20 mM LiCl to determine if continual LiCl exposure
influenced embryo development in a dose-dependent
manner. To ascertain that repression of development by
LiCl was due to GSK-3 and not IMPase inhibition,
zygotes were cultured for 72 hr in KSOM alone or
containing20mMLiCl, 20mMKCl (molarity control), or
Molecular Reproduction and Development. DOI 10.1002/mrd
180 N. ACEVEDO ET AL.
20 mM L-690, 330 (specific IMPase inhibitor). Zygotes
were cultured for 30 hr in KSOM alone, 20 mM LiCl, or
20 mM KCl, then washed and transferred to KSOM
alone for up to 48 hr total culture to assess if embryos
could regainmitotic potential after removal fromGSK-3
inhibition. To verify that block of development at two-
cell stage was due to selective inhibition of GSK-3 not
CDK activity, zygotes were cultured for 96 hr in KSOM
alone, 20 mM LiCl, 20 mM alsterpaullone, or 80 mM
roscovitine (selectiveCDK1/2/5 inhibitor). Zygoteswere
individually cultured in 50 ml microdrops for 24 hr in
KSOM alone or containing 20 mMLiCl, 20 mMKCL, or
20 mM alsterpaullone then examined at 3 hr intervals
using a Leica DMIRB inverted microscope with Hoff-
man modulation contrast optics (40) to assess nuclear
and cytoplasmic events during the first mitotic division.
After 24 hr of culture, embryos were fixed and stained
withHoescht 33342 to visualize chromatin. Imageswere
captured and processed with SPOTTM RT Slider digital
camera and software (Diagnostic Instruments, Sterling
Heights, MI).
Statistical Analyses
Each developmental study was performed in dupli-
cate (Western blot analyses) or triplicate (morphological
analyses), and cumulative results were analyzed using
Chi-square (w2) analysis. Differences were considered
significant at of P< 0.01.
RESULTS
GSK-3 is Expressed During Early
Preimplantation Embryo Development and
Co-Localizes With First Mitotic Spindle
Activity of GSK-3 may be required for proper
progression of fertilized oocytes through the firstmitotic
cleavage events.Western blot analysiswasperformed to
determine presence/absence of GSK-3 protein in
denuded mature oocytes and preimplantation embryos.
Isoforms of GSK-3 a and b (51 and 47 kDa, respectively)
were identified in mouse MII oocytes, and in one-cell,
two-cell, four-cell, and blastocyst-stage embryos. Addi-
tionally, there was differential expression of a and b
isoforms during preimplantation embryonic develop-
ment (Fig. 1A). Specifically, densitometry analysis of a
and b isoforms showed a 2:1 (a:b) expression ratio inMII
oocytes and zygotes through four-cell embryos, whereas
expression of GSK-3 in blastocysts and mouse brain
(positive control tissue) was equivalent for each isoform.
Both GSK-3a and b were phosphorylated at tyrosine
residues throughout preimplantation embryo develop-
ment, suggesting a basal state of constitutively active
GSK-3 (Fig. 1B). With respect to GSK-3 inactivation,
which involvesN-terminal serine phosphorylation, there
appeared to be greater phosphorylation of S9 (GSK-3b)
than S21 (GSK-3a) residues throughout oocyte matura-
tion and early embryonic divisions. However, by the
blastocyst stage, only GSK-3b (and not GSK-3a) was
Molecular Reproduction and Development. DOI 10.1002/mrd
Fig. 1. Glycogen synthase kinase-3 (GSK-3) a and b expression and
phosphorylation during early preimplantation embryo development.
Immunoblot analysis of GSK-3 a and b in mature (MII) oocytes, and in
early cleavage stage embryos.Mouse brain total protein (1 mg)wasused
as positive control forGSK-3 a and b expression. Total protein fromMII
oocytes, one-cell, two-cell, four-cell, and blastocyst embryo lysates (80–
200 embryos) were loaded per lane. A: Preimplantation embryos
contained bothGSK-3 aand b, but therewasa differential expression of
GSK-3 a to b isoforms in early preimplantation embryos compared to
blastocyst embryosandmousebrain control.Westernblotswereprobed
with an antibody that recognized both a and b isoforms. B: GSK-3
phosphorylation at a tyrosine residue (Y279 of a/Y216 of b) indicates
constitutive activation, whereas phosphorylation at an N-terminal
serine residue (S21 of a/S9 of b) indicates regulated inhibition. Blots
were probed with antibodies against phospho-GSK-3 a/b (Y279/216)
and phospho-GSK-3 a/b (S21/S9), respectively.
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phosphorylated at the serine residue, similar to somatic
cell control (Fig. 1B).
Immunocytochemical analysis showed accumulation
of GSK-3 a/b surrounding metaphase plate during
the first embryonic mitosis (Fig. 2A). Co-staining
cells for GSK-3a and b-tubulin confirmed that GSK-3
co-localized with mitotic spindles as cells entered and
progressed through metaphase (Fig. 2B). As cells pro-
gressed through anaphase, GSK-3 became more dif-
fusely distributed throughout the cytoplasm (Fig. 2B).
GSK-3 Activity is Critical for Normal Chromatin
Segregation and Cytokinesis
To determine importance of GSK-3 in early embryo
mitotic progression, anti-GSK-3 a/b antibody was
microinjected into the cytoplasm of pronuclear-stage
embryos and cleavage events were assessed in 24-hr
intervals for 48 hr. Microinjection controls were similar
to each other in rate of development at 24 and 48 hr of
culture (Table 1).Microinjection of anti-GSK-3 antibody
significantly compromised development past the two-
cell stage by 48 hr of culture compared to controls
(Table 1). As important, the majority of embryos
microinjected with anti-GSK-3 that underwent the first
mitotic division remained arrested at the two-cell stage
by 72 hr, without exhibiting cellular fragmentation or
degeneration (data not shown).
To ascertain if pharmacological inhibition of GSK-3
activity affected early mitotic progression, in vivo-
generated zygotes were collected at the pronuclear
stage, cultured for 72 hr in KSOM alone or with 1, 10,
Molecular Reproduction and Development. DOI 10.1002/mrd
Fig. 2. GSK-3 associates with the mitotic spindle apparatus during
the first cleavage event. A: Immunostaining of embryo during the first
mitotic metaphase showed accumulation of GSK-3a/b protein (red)
around the condensed chromatin (blue) of the metaphase plate.
Immunostaining control (NIMS) showed no reactivity (a; insert). B:
Representativemicrographs of GSK-3a protein distribution in relation
to the spindle apparatus during the first mitotic prometaphase,
metaphase, and anaphase. GSK-3a closely associates with the spindle
microtubules (depicted by polymerized b-tubulin (green)) during
prometaphase and metaphase, and then becomes more diffuse
throughout the cytoplasm during anaphase. Immunostaining control
(NIRS) showed no reactivity (b; insert). Bar, 10 mm.
TABLE 1. Effects of Anti-GSK-3a/b Antibody
Microinjection on Development of Embryos Cultured








PBS alonea 70 85 79




GSK-3 antibody 110 61 6c
N, number of embryos assessed in each treatment group.
aVehicle control for mouse IgG microinjection.
bVehicle control for GSK-3 antibody microinjection.
cValue significantly different from controls.
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or 20 mM LiCl, and examined microscopically in 24-hr
intervals. Similar to anti-GSK-3 antibody microinjec-
tion, embryo development was significantly compro-
mised in a dose-dependent manner by 48 hr of culture
with significantly fewer embryos developing beyond the
two-cell stage in 10 and 20 mM LiCl (Fig. 3A). Interest-
ingly, embryos cultured in LiCl for 72 hr that failed to
cleave past the two-cell stage had blastomeres that
appeared viable and did not exhibit fragmentation.
These results were comparable to those observed follow-
ing antibody neutralization.
LiCl inhibits both GSK-3 and IMPase (Berridge et al.,
1989; Klein and Melton, 1996). To ascertain that
repression of development by LiCl was not due to
inhibition of IMPase activity, one-cell embryos were
cultured for 72 hr in KSOM alone, 20 mM LiCl, 20 mM
KCl (molarity control for LiCl), or 20 mM L-690, 330
(specific IMPase inhibitor). At 48 hr of culture, only
zygotes cultured in LiCl had significantly compromised
development beyond the two-cell stage compared to
KSOM, KCl, and L-690, 330 (Fig. 3B). To establish if
embryos could regain mitotic potential after removal
from GSK-3 inhibition, one-cell embryos were cultured
for up to 30 hr in KSOM, 20 mM LiCl, or 20 mM KCl,
then washed and transferred to KSOM alone for up to
48 hr total culture. Embryos cultured in LiCl for 24 hr
Molecular Reproduction and Development. DOI 10.1002/mrd
Fig. 3. Pharmacological inhibition of GSK-3 via lithium chloride
(LiCl) blocks embryonic development past the two-cell stage. A: LiCl
compromised embryo development in a dose-dependent manner.
Percentage of zygotes cultured for 48 hr in either control media, or in
thepresence of 1mM,10mM, or 20mMLiCl,withnormal cleavagepast
the two-cell stage. (N¼ 76–112 embryos/treatment). Columns with
asterisks indicate significantly different from control (P<0.001).
B: Inhibition of GSK-3, but not IMPase, activity during early embryo
development blocked development at the two-cell stage. Percentage of
time-appropriate cleavage after zygotes were cultured for 24 or 48 hr in
either controlmedia (KSOM), 20mMLiCl, 20mMKCl, or 20 mML-690,
330. (N¼ 85–102 embryos/treatment). a,b; c,d: Columns with similar
colors and different letters are significantly different.
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had significantly reduced cleavage rates compared to
those cultured in KSOM or KCl (Fig. 4). By 48 hr, LiCl
treated embryos did not undergo significant new
cleavage in relation to those cultured in KSOM and
KCl treated embryos, suggesting an irreversible disrup-
tion of mitotic cell cycle progression.
To validate that observed blocks on mitotic progres-
sion were due to inhibition of GSK-3 and not inhibition
of CDK activity, zygotes were cultured in presence of
either 20 mM LiCl, 20 mM alsterpaullone, or 80 mM
roscovitine. Administration of 20 mMalsterpaullone has
been shown to prevent in vivo phosphorylation of tau
epitopes phosphorylated by GSK-3 without affecting
phosphorylation of tau epitopes phosphorylated by
CDK5 (Leost et al., 2000; Tatebayashi et al., 2004). By
48 hr, there was a marked developmental difference
between embryos cultured in either LiCl or alsterpaul-
lone, which failed to cleave past the two-cell stage, and
embryos cultured in roscovitine, inwhich 21%of zygotes
developed to the four-cell stage (Table 2). As important,
there was a greater rate of degeneration in the
roscovitine-treated embryos at both 24 and 48 hr of cul-
ture, compared to all other treatment groups (Table 2).
Thus, pharmacological inhibition of GSK-3 activity via
LiCl and/or alsterpaullone mimics the developmental
defect following immunoneutralization of endogenous
GSK-3 protein prior to the first embryonic cell division.
To further characterize the nature of this arrested
development, we examined GSK-3-inhibited embryos
for both nuclear and cytoplasmic anomalies. Zygotes
were cultured for 24 hr in KSOM or 20 mM LiCl, and
microscopically examined at 3 hr-intervals. LiCl treat-
ment didnot significantly influence timingof pronuclear
migration, however, timing of pronuclear membrane
breakdown and mitosis initiation was significantly
different between treatments (Table 3). By 24 hr of
Molecular Reproduction and Development. DOI 10.1002/mrd
TABLE 2. Pharmacological Inhibition of GSK-3 via Alsterpaullone Blocks Embryo









at 24 hr (%)
Degeneration
at 48 hr (%)
KSOMa 41 88 76 0 10
20 mM LiCl 45 42d 0d 9 9
DMSO aloneb 45 92 89 9 9
20 mMalsterpaullone 44 80 0d 9 18
DMSO alonec 32 83 81 7 12
80 mM roscovitine 40 56d 21d 29 33
N, number of embryos assessed in each treatment group.
aControl for 20 mM LiCl.
bVehicle control for 20 mM alsterpaullone.
cVehicle control for 80 mM roscovitine.
dValues significantly different from control [P< 0.01].
Fig. 4. Removal from GSK-3 inhibitory media after 30 hr of culture did not result in resumption of
mitotic potential. Percentage of time-dependent cleavage measured after 24 hr of total culture in either
control media (KSOM), 20 mM LiCl, or 20 mM KCl. At 30 hr of culture, embryos in all treatment groups
were washed and cultured in control media. Percentage of time-appropriate cleavage after removal from
inhibitor mediameasured at 48 hr of total culture (N¼ 82–92 embryos/treatment). a,b; c,d: Columns with
similar colors and different letters are significantly different.
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culture (48 hr post-hCG), LiCl treatment significantly
compromised both nuclear formation and cytokinesis
compared to control (Table 3).
Nuclear staining of embryos after 24 hr of culture in
either KSOM, 20 mM KCl, 20 mM LiCl, or 20 mM
alsterpaullone showed abnormal chromatin segregation
patterns in GSK-3 inhibited embryos compared to
controls (Fig. 5). Control embryos (KSOM, KCl) devel-
oped into two distinct blastomeres with properly
segregated daughter nuclei. GSK-3 inhibition (LiCl,
alsterpaullone) showed abnormal chromatin segrega-
tionpatterns, evidencedby incomplete karyokinesis and
micronuclei formation. As important, both timing and
completion of cytokinesis were also compromised in
conjunctionwith this incomplete karyokinesis inGSK-3
inhibited embryos (Table 1, Fig. 5).
DISCUSSION
In the present study we have shown that GSK-3
protein is expressed during mammalian preimplanta-
tion embryo development in a temporal, isoform-specific
manner. GSK-3 is a highly conserved serine/threonine
protein kinase that consists of two closely related
isoforms, a and b (Woodgett, 1990). Despite displaying
similar biochemical properties to the a isoform, the
GSK-3b isoform has been more thoroughly investigated
in mammalian somatic cell systems because it more
closely resembles its Drosophila homologue, Zw3,
supporting the assumption that only the b isoform is
involved inWnt signaling in mammalian cells (Hoeflich
et al., 2000). Our data showed a differential expression
ofGSK-3a toGSK-3b throughout oocytematuration and
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TABLE 3. Inhibition of GSK-3 Activity Disrupted Normal Karyokinesis and
Cytokinesis During the First Mitotic Division
Time (post-hCG) Developmental event
Treatment
KSOM (%Total) LiCl (%Total)
N¼ 38 N¼ 39
28 hr Pronuclear migration 86 78
35 hr Pronuclear membrane breakdown 43 19*
48 hr Complete karyokinesis 95 28*
48 hr Complete cytokinesis 95 40*
N, number of embryos assessed in each treatment group.
Asterisk (*) denotes significant difference in timeof developmental event betweenLiCl-treated
group and control (KSOM).
Fig. 5. Inhibition of GSK-3 activity resulted in chromatin segregation abnormalities. Representative
micrographs of embryos cultured for 24 hr in either KSOM, 20 mM KCl, 20 mM LiCl, or 20 mM
alsterpaullone, then fixed and stained with Hoechst 33342 (white in inset; dark grey in brightfield phase
contrast overlays) to visualize the chromatin segregation patterns. Bar, 10 mm.
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early embryonic development. Of greatest interest was
the predominant expression of GSK-3a in early dividing
embryos (two- and four-cell stage), and the shift to an
increased expression of GSK-3b by the blastocyst stage.
This would indicate that GSK-3b is either a gene that
is transcribed and translated in response to ZGA and/or
that GSK-3bmay be an important kinase in preimplan-
tation embryonic cell fate determination as embryonic
blastomeres make the transition to differentiated cell
populations. It will be of interest in future studies to
determine if cells of the trophoblast, or inner cell mass,
preferentially express GSK-3b.
Our results indicate a temporal regulation of GSK-3
activity during oocyte maturation and early embryonic
development via differential phosphorylation of GSK-3
serine (S21ofa/S9 ofb) and tyrosine (Y279ofa/Y216 ofb)
residues. Activation of the PI3K signaling pathway
mediates GSK-3 activity through phosphorylation and
activation of PKB, which, in turn, phosphorylates and
inactivates GSK-3 on an N-terminal serine (S21/S9)
residue (Cohen and Frame, 2001). The induced inhibi-
tion of GSK-3 activity leads to dephosphorylation of
GSK-3 substrates via protein phosphatases (Cohen and
Frame, 2001). In resting mammalian cells, the tyrosine
(Y279/Y216) residues of GSK-3a/b are constitutively
phosphorylated, promoting kinase activation. Our
results indicate that during oocyte maturation and
early embryonic development, tyrosine (Y279/Y216)
phosphorylation patterns mimic overall protein expres-
sion patterns for each isoform.However, serine (S21/S9)
phosphorylation patterns were distinctly different from
protein expression during preimplantation embryo
development. Although a was the predominant isoform
expressedduringearly embryonicdivisions, bothaandb
were phosphorylated on the serine residue during these
stages. Interestingly, at the blastocyst stage only the b
isoform exhibited serine phosphorylation, a pattern
similar to that observed in the somatic cell control
(mouse brain). These phosphorylation patterns indicate
differential regulation of GSK-3 activity between early
and late embryonic development via different isoforms.
Immunoneutralization of endogenous GSK-3 protein
function following fertilization but prior to the first
mitotic metaphase resulted in a distinct block on
development past the two-cell stage. A limitation to
the immunoneutralization approach is inability to test
reversibility of inhibitory effects. To address this issue,
we employed a combined pharmacological approach to
investigate early developmental processes regulated by
GSK-3 in mouse embryos. In assessing the appropriate
physiological targets of anypharmacological inhibitor, it
is important to consider that selective substrate inhibi-
tion by a pharmacological agent in a cell-free extract
does not necessarily translate to substrate inhibition
in vivo. In cell-free extracts, alsterpaullone potently
inhibitsGSK-3andCDK5activity at IC50 values of 0.004
and 0.04 mM, respectively (Leost et al., 2000). In cell
culture, however, 20 mM alsterpaullone more potently
inhibits activity ofGSK-3 thanCDK5,at a concentration
much higher than the IC50 for either kinase (Leost et al.,
2000; Tatebayashi et al., 2004). The combined use of
alsterpaullone andLiCl as pharmacological inhibitors of
GSK-3 is validated by reports that alsterpaullone
potently and selectively inhibits GSK-3 and CDK1/2/5
in vitro, whereas LiCl potently inhibits GSK-3 with no
known inhibitory effect on CDK activity (Klein and
Melton, 1996;Davies et al., 2000;Leost et al., 2000;Phiel
andKlein, 2001). In our studies, embryos cultured in the
selective CDK inhibitor, roscovitine, had significantly
compromised development at the two-cell stage and
beyond, and displayed an increased rate of degeneration
and fragmentation, compared to controls. In compar-
ison, embryos cultured in either LiCl or alsterpaullone
failed to cleave past the first mitotic division without
exhibiting cellular fragmentation, and resulted in
chromatin and cytoskeletal abnormalities. Thus, within
this experimental model system, we have demonstrated
a common developmental consequence of GSK-3 inhibi-
tors LiCl and alsterpaullone, yet a very different
developmental influence of the CDK inhibitor, roscov-
itine.
Despite a comparable block on development past the
two-cell stage, LiCl and alsterpaullone-treated zygotes
did differ in the percent that underwent the first mitotic
division (Table 2). The cause for this discrepancy is
currently unknown. One explanation may be that the
two pharmacological inhibitors exhibit different poten-
cies that relate to their mode of interaction with GSK-3
(Leost et al., 2000;Ryves andHarwood, 2001; Song et al.,
2002; Bertrand et al., 2003; Zhang et al., 2003).
We have shown that both GSK-3-neutralizing anti-
body microinjection and pharmacological inhibition
irreversibly compromised early preimplantation
embryo development through a developmental block
characterized by abnormal chromatin segregation and
incomplete cytokinesis. This does not appear to be a
consequence of induction of an apoptotic or necrotic
response, because this developmental block is not
followed by embryo fragmentation, degeneration, or
death. Irreversible disruption of development past the
two-cell stage suggested that the influence of GSK-3
inhibition results in an irremediable structural pro-
blem. This was investigated by quantifying nuclear and
cytoplasmic transitions during the first mitotic division
and nuclear and cytoplasmic structure of the arrested
embryos. Results indicate that inhibition of GSK-3
activity caused uncoupling of cytokinesis from comple-
tion of karyokinesis, and compromised completion of
karyokinesis.
Equal separation of the genome duplicated during
mitosis depends on proper formation and function of
mitotic spindles (Tournebize et al., 1997;Nasmyth et al.,
2001). Several studies have implicated GSK-3 in
regulation of mitotic microtubule dynamics that pro-
duces a competent spindle apparatus for successful
chromosomal segregation (Lovestone et al., 1996; Dox-
sey, 2001; Wakefield et al., 2003). Wakefield and
colleagues (2003) showed that GSK-3 protein associates
withmicrotubules along the length of the spindle. In the
present study, GSK-3 was also found to co-localize with
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the first embryonic mitotic spindle. This intracellular
location, in conjunctionwithmicroscopic observations of
incomplete chromatin segregation at thefirst embryonic
mitotic division following GSK-3 inhibition, supports
a role for GSK-3 in proper spindle function and/or
completion of chromatin separation. From a structural
and developmental focus one can appreciate that this
incomplete karyokinesis, in association with a structu-
rally and/or functionally abnormal spindle, may physi-
cally hinder the completion of cytokinesis observed in
this study.
In conclusion, we have demonstrated that GSK-3
activity is critical for proper and timely progression of
mammalian zygotes through thefirstmitotic division, in
that inhibition of GSK-3 activity during the first cell
cycle leads to abnormal chromatin segregation and
failure to develop past the two-cell stage. As important,
we found that GSK-3 plays a role in mediating timing
and completion of cytokinesis. Further investigation is
required to determine if GSK-3 influences proper
chromatin segregation during the early cleavage events
of the preimplantation embryo via regulation of spindle
function, chromatin remodeling proteins, or GSK-3
phosphoprotein substrates that translate the GSK-3
signal necessary for completion of the first embryonic
mitotic division.
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